|01:00 AM ET|
Morgan Lewis partner Robin M. Silva will present "Bioequivalence and the 'Same Active Ingredient' vis-à-vis Patentability" at a Paragraph IV Disputes West conference pre-conference workshop.
This hands-on workshop provides an in-depth review of the Hatch-Waxman schematic and other IP and regulatory basics relative to small molecules and biologics, as well as critical insights into the commercialization and the pre-approval processes for these products. The workshop leaders discuss the dynamics of the IP and regulatory backdrop underlying each Paragraph IV dispute and the complexities of the Hatch-Waxman litigation challenges presented during the main conference.
Her speech will cover:
More information about the conference can be found at http://www.americanconference.com/PIVdisputes/workshop.htm.